Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insmed (INSM) Interest Expenses (2016 - 2026)

Insmed's Interest Expenses history spans 16 years, with the latest figure at $20.1 million for Q1 2026.

  • Quarterly Interest Expenses fell 6.89% to $20.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $82.3 million through Mar 2026, down 3.67% year-over-year, with the annual reading at $83.8 million for FY2025, 1.32% down from the prior year.
  • Interest Expenses came in at $20.1 million for Q1 2026, down from $20.6 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $21.6 million in Q1 2025 to a low of $3.3 million in Q1 2022.
  • The 5-year median for Interest Expenses is $20.6 million (2025), against an average of $17.5 million.
  • Year-over-year, Interest Expenses tumbled 70.18% in 2022 and then soared 514.21% in 2023.
  • Insmed's Interest Expenses stood at $16.4 million in 2022, then increased by 26.38% to $20.8 million in 2023, then grew by 3.69% to $21.6 million in 2024, then dropped by 4.41% to $20.6 million in 2025, then fell by 2.51% to $20.1 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Interest Expenses are $20.1 million (Q1 2026), $20.6 million (Q4 2025), and $20.4 million (Q3 2025).